BRIEF-Merck says FDA has accepted for review supplemental biologics license application for Keytruda
April 13, 2016 at 07:11 AM EDT
* Says fda granted priority review with a pdufa, or target action, date of aug. 9
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.